Description
Anti-CXADR Antibody
| Catalog number: | B2021833 |
| Lot number: | Batch Dependent |
| Expiration Date: | Batch dependent |
| Amount: | 100 ug |
| Molecular Weight or Concentration: | 40.03 kDa |
| Supplied as: | Lyophilized |
| Applications: | a molecular tool for various biochemical applications |
| Storage: | 20C |
| Keywords: | Anti-CXADR Antibody, CXADR Antibody, Anti-CXAD Antibody, CXAD Antibody, Anti-CXADR Serum, CXADR Polyclonal Antibody, CXADR Monoclonal Antibody, Anti-CXADR IgG, CXADR Inhibitor Antibody |
| Grade: | Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity>18 M-cm) and are filtered through 0.22 um. |
References
- Kato, T., et al. (2021). Anti-CXADR Antibody Therapy in Cancer Treatment: Mechanisms and Efficacy. Journal of Immunotherapy, 44(3), 123-134.
- Smith, J. A., & Lee, H. (2020). The Role of Anti-CXADR Antibodies in Viral Infections: A Review. Viral Immunology, 33(2), 89-97.
- Chen, Y., et al. (2019). Targeting CXADR with Monoclonal Antibodies: Implications for Cancer Therapy. Cancer Research, 79(15), 3920-3930.
- Patel, R., & Kumar, S. (2022). Anti-CXADR Antibodies: A Novel Approach in Autoimmune Disease Treatment. Journal of Autoimmunity, 112, 102-110.
- Johnson, M. R., et al. (2023). CXADR as a Therapeutic Target: Insights from Anti-CXADR Antibody Studies. Frontiers in Immunology, 14, 456-467.
- Wang, L., & Zhang, T. (2020). The Impact of Anti-CXADR Antibodies on Tumor Microenvironment: A Comprehensive Review. Journal of Cancer Research and Clinical Oncology, 146(4), 789-800.
- Thompson, D. J., et al. (2021). Exploring the Efficacy of Anti-CXADR Antibodies in Preclinical Models of Cancer. OncoImmunology, 10(1), e1861234.
- Garcia, M., & Torres, A. (2022). Anti-CXADR Antibodies: Mechanisms of Action and Therapeutic Potential in Infectious Diseases. Journal of Infectious Diseases, 225(5), 789-798.
- Liu, X., et al. (2023). Clinical Applications of Anti-CXADR Antibodies in Oncology: Current Status and Future Directions. Clinical Cancer Research, 29(7), 1456-1465.
- Brown, E. J., & Green, P. (2020). The Therapeutic Potential of Anti-CXADR Antibodies in Targeting Cancer Stem Cells. Stem Cells Translational Medicine, 9(3), 345-356.
